BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29887261)

  • 1. Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma.
    Sasaki K; Margonis GA; Andreatos N; Chen Q; Barbon C; Bagante F; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Endo I; Aucejo FN; Pawlik TM
    HPB (Oxford); 2018 Oct; 20(10):956-965. PubMed ID: 29887261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging for intrahepatic cholangiocarcinoma.
    Kokudo N; Arita J
    Liver Int; 2010 Aug; 30(7):931-3. PubMed ID: 20408948
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma.
    Buettner S; Galjart B; van Vugt JLA; Bagante F; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Groot Koerkamp B; Pawlik TM
    J Surg Oncol; 2017 Dec; 116(8):1085-1095. PubMed ID: 28703880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas.
    Sotiropoulos GC; Miyazaki M; Konstadoulakis MM; Paul A; Molmenti EP; Gomatos IP; Radtke A; Baba HA; Beckebaum S; Brokalaki EI; Ohtsuka M; Schwartz ME; Broelsch CE; Sgourakis G
    Liver Int; 2010 Aug; 30(7):996-1002. PubMed ID: 20141593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
    Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG
    HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative risk score for prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma: Report of a collaborative, international-based, external validation study.
    Brustia R; Langella S; Kawai T; Fonseca GM; Schielke A; Colli F; Resende V; Fleres F; Roulin D; Leyman P; Giacomoni A; Granger B; Fartoux L; De Carlis L; Demartines N; Sommacale D; Sanches MD; Patrono D; Detry O; Herman P; Okumura S; Ferrero A; Scatton O;
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):560-571. PubMed ID: 31718919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers.
    Cheng Z; Lei Z; Si A; Yang P; Luo T; Guo G; Zhou J; Wang X; Li Z; Xia Y; Li J; Wang K; Yan Z; Wei W; Hartmann D; Hüser N; Lau WY; Shen F
    HPB (Oxford); 2019 Dec; 21(12):1656-1666. PubMed ID: 31307889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system.
    Hahn F; Müller L; Mähringer-Kunz A; Schotten S; Düber C; Hinrichs JB; Maschke SK; Galle PR; Bartsch F; Lang H; Weinmann A; Kloeckner R
    PLoS One; 2020; 15(2):e0228501. PubMed ID: 32012198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of 84 intrahepatic cholangiocarcinoma patients].
    Li FH; Chen XQ; Luo HY; Li YH; Wang F; Qiu MZ; Teng KY; Li ZH; Xu RH
    Ai Zheng; 2009 May; 28(5):528-32. PubMed ID: 19624884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of prognostic factors influencing the outcome of intrahepatic cholangiocarcinoma].
    Zhang L; Cai JQ; Bi XY; Zhao JJ; Xing GS; Yan T; Fu YX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):845-8. PubMed ID: 20137350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
    Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
    J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
    Spolverato G; Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2017 May; 115(6):696-703. PubMed ID: 28194791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.
    Wang Y; Li J; Xia Y; Gong R; Wang K; Yan Z; Wan X; Liu G; Wu D; Shi L; Lau W; Wu M; Shen F
    J Clin Oncol; 2013 Mar; 31(9):1188-95. PubMed ID: 23358969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score.
    Jiang W; Zeng ZC; Tang ZY; Fan J; Sun HC; Zhou J; Zeng MS; Zhang BH; Ji Y; Chen YX
    Ann Oncol; 2011 Jul; 22(7):1644-1652. PubMed ID: 21212156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of neutrophil/prealbumin ratio for intrahepatic cholangiocarcinoma undergoing curative resection.
    Huang XT; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    HPB (Oxford); 2018 Dec; 20(12):1215-1222. PubMed ID: 30078755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
    Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.